Dalmark Pharma Chem Private Limited - Company Profile

It is a pharma private limited company based in Navimumbai, Maharashtra, India, established in 2020.
2020 Navimumbai, Maharashtra, India Active
Last Updated:
About Dalmark Pharma Chem Private Limited

Dalmark Pharma Chem Private Limited, a active private limited company, was established on 19 August 2020 in Navimumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24233MH2020PTC344094. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹20.00 K .

Its leadership includes Monil Nandawat (Director), Dinesh Kumar Malara (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-402 New Ambica Develpoers Plot 20 Sec 25, Navimumbai, Maharashtra, 410206.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233MH2020PTC344094

  • Registration Number

    344094

  • Incorporation Date

    19 August 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹20.00 K

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 20.00 K
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 142.45%
  • Ebitda **** -1967.10%
  • Net Worth 69.62%
  • Total Assets **** 2379.52%
Company report

Dalmark Pharma Chem Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dalmark Pharma Chem Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dalmark Pharma Chem Private Limited?
Current Directors
Name Designation Appointment Date Status
Monil Nandawat Director 19 Aug 2020 Current
Dinesh Kumar Malara Director 19 Aug 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dalmark Pharma Chem.

Dalmark Pharma Chem Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 142.45% increase in profit. The company's net worth Soared by an impressive increase of 69.62%.

Dalmark Pharma Chem revenue growth over time
Dalmark Pharma Chem profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
2379.52%
*******
*******
*******
*******
Profit or Loss
*******
142.45%
*******
*******
*******
*******
Net Worth
*******
69.62%
*******
*******
*******
*******
EBITDA
*******
-1967.10%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dalmark Pharma Chem?

In 2021, Dalmark Pharma Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dalmark Pharma Chem?

Dalmark Pharma Chem has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dalmark Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dalmark Pharma Chem's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dalmark Pharma Chem
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dalmark Pharma Chem Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Dalmark Pharma Chem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Monil Nandawat was appointed as a Director was appointed as a Director on 19 Aug 2020 & has been associated with this company since 5 years 5 months . was documented.

  • Director Appointment

    The activity Dinesh Kumar Malara was appointed as a Director was appointed as a Director on 19 Aug 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Company Incorporation

    The activity Dalmark Pharma Chem Private Limited was registered on 19 Aug 2020 with Roc Mumbai & aged 5 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dalmark Pharma Chem Private Limited?

The CIN of Dalmark Pharma Chem Private Limited is U24233MH2020PTC344094.

Where is Dalmark Pharma Chem Private Limited headquartered?

Dalmark Pharma Chem Private Limited is headquartered at A-402 New Ambica Develpoers Plot 20 Sec 25, Navimumbai, Maharashtra, 410206.

When was Dalmark Pharma Chem Private Limited incorporated?

Dalmark Pharma Chem Private Limited was incorporated on 19 August 2020.

Who are the current directors of Dalmark Pharma Chem Private Limited?

The current directors of Dalmark Pharma Chem Private Limited are

What is the primary industry of Dalmark Pharma Chem Private Limited?

The primary industry of Dalmark Pharma Chem Private Limited is Pharma.

Is Dalmark Pharma Chem Private Limited a listed company?

Dalmark Pharma Chem Private Limited is unlisted.

What is the capital structure of Dalmark Pharma Chem Private Limited?

The authorized capital of Dalmark Pharma Chem Private Limited is ₹0.10 M, and the paid-up capital is ₹20.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available